Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment

Fig. 1

Correlation between p-tau217 and FTP-PET and their association with PIB-PET. Each scatter point shows data from one patient. The shaded area indicates 95% CI of the regression line. In panel A, data points labeled I, II, III, and IV correspond to patients with ~ 0.7 pg/mL p-tau217 concentration; their corresponding FTP-PET SUVR maps are shown on the right panel

Back to article page